Linkage of human tumor necrosis factor-alpha to human osteoporosis by sib-pair analysis

Genes and Immunity

Volumn 1, Issue 4, 2000, Pages 260-264

  Ota, N ^a   Hunt, S C ^b   Nakajima, T ^a   Suzuki, T ^c   Hosoi, T ^c   Orimo, H ^c   Shirai, Y ^a   Emi, M ^a  

^a NIPPON MEDICAL SCHOOL   (Japan)

^b UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^c TOKYO METROPOLITAN INSTITUTE OF GERONTOLOGY   (Japan)

Author keywords

Bone mineral density; Microsatellite polymorphism; Osteopenia; Osteoporosis; Sib pair linkage; Tumor necrosis factor alpha gene

Indexed keywords

MICROSATELLITE DNA; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; BONE DENSITY; FEMALE; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; GENOTYPE; HUMAN; METABOLIC BONE DISEASE; MIDDLE AGED; OSTEOPOROSIS;

ADULT; AGED; AGED, 80 AND OVER; BONE DENSITY; BONE DISEASES, METABOLIC; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MICROSATELLITE REPEATS; MIDDLE AGED; OSTEOPOROSIS; POLYMORPHISM, GENETIC; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0034576287     PISSN: 14664879     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.gene.6363668     Document Type: Article

References (32)

1. Pocock NA, Eisman JA, Hopper JL, Yeates MG, Sambrook PN, Eberl S. Genetic determinants of bone mass in adults. A twin study. J Clin Invest 1987; 80: 706-710.
2. Krall EA, Dawson-Hughes B. Heritable and life-style determinants of bone mineral density. J Bone Miner Res 1993; 8: 1-8.
3. Raisz LG. Local and systemic factors in the pathogenesis of posteoporosis. N Engl J Med 1988; 318: 818-828.
4. Luben RA, Mundy GR, Trummel CL, Raisz LG. Partial purification of osteoclast-activating factor from phytohemagglutinin-stimulated human leukocytes. J Clin Invest 1974; 53: 1473-1480.
5. Johnson RA, Boyce BF, Mundy GR, Roodman GD. Tumor producing human tumor necrosis factor induced hypercalcemia and osteoclastic bone resorption in nude mice. Endocrinology 1989; 124: 1424-1427.
6. Mundy GR. Inflammatory mediators and the destruction of bone. J Periodontal Res 1991; 26: 213-217.
7. Bertolini DR, Nedwin GE, Bringman TS, Smith DD, Mundy GR. Stimulation of bone resorption and inhibition of bone formation in vitro by human tumor necrosis factors. Nature 1986; 319: 516-518.
8. Cohen-Solal ME, Graulet AM, Denne MA, Gueris J, Baylink D, de Vernejoul MC. Peripheral monocyte culture supernatants of menopausal women can induce bone resorption: involvement of cytokines. J Clin Endocrinol Metab 1993; 77: 1648-1653.
9. Pfeilschifter J, Chenu C, Bird A, Mundy GR, Roodman GD. Interleukin-1 and tumor necrosis factor stimulate the formation of human osteoclast-like cells in vitro. J Bone Miner Res 1989; 4: 113-118.
10. Ralston SH, Russell RG, Gowen M. Estrogen inhibits release of tumor necrosis factor from peripheral blood mononuclear cells in postmenopausal women. J Bone Miner Res 1990; 5: 983-988.
11. Morrison NA, Qi JC, Tokita A et al. Prediction of bone density from vitamin D receptor alleles. Nature 1994; 367: 284-287.
12. Sano M, Inoue S, Hosoi T et al. Association of estrogen receptor dinucleotide repeat polymorphism with osteoporosis. Biochem Biophys Res Commun 1995; 217: 378-383.
13. Kobayashi S, Inoue S, Hosoi T, Ouchi Y, Shiraki M, Orimo H. Association of bone mineral density with polymorphism of the estrogen receptor gene. J Bone Miner Res 1996; 11: 306-311.
14. Grant SFA, Reid DM, Blake G, Herd R, Fogelman I, Ralston SH. Reduced bone density and osteoporosis associated with a polymorphic Sp1 site in the collagen type I alpha 1 gene. Nature Genet 1996; 14: 203-205.
15. Beutler BA. Application of transcriptional and posttranscriptional reporter constructs to the analysis of tumor necrosis factor gene regulation. Am J Med Sci 1992; 303: 129-133.
16. Economou JS. Genetic analysis of the human tumor necrosis factor alpha/cachectin promoter region in a macrophage cell line. J Exp Med 1989; 170: 321-326.
17. Jongeneel CV. Transcriptional of the tumor necrosis factor alpha gene. Immunobiology 1995; 193: 210-216.
18. Wilson AG, di Giovine FS, Blakenbore AIF, Duff GW. Single base polymorphism in the human tumor necrosis factor alpha (TNF alpha) gene detectable by Nco I restriction of PCR product. Hum Mol Gent 1992; 1: 353.
19. Wilson AG, Symons JA, Mcdowell TL, Mcdevitt HO, Duff GW. Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation. Proc Natl Acad Sci USA 1997; 94: 3195-3199.
20. Braun N, Michel U, Ernst BP et al. Gene polymorphism at position -308 of the tumor necrosis factor (TNF-alpha) in multiple sclerosis and its influence on the regulation of TNF-alpha production. Neurosci Lett 1996; 215: 75-78.
21. Kroeger KM, Carville KS, Abraham LJ. The -308 tumor necrosis factor-alpha promoter polymorphism effects transcription. Mol Immunol 1997; 34: 391-399.
22. Jacob CO, Froken Z, Lewis GD, Koo M, Hansen JA, McDevitt HO. Heritable major histocompatibility complex class II-associated differences in production of tumor necrosis factor alpha: relevance to genetic predisposition to systemic lupus erythematosus. Proc Natl Acad Sci USA 1990; 87: 1233-1237.
23. Prociot F, Briant L, Jongeneel CV et al. Association of tumor necrosis factor (TNF) and class II major histocompatibility complex alleles with the secretion of TNF-alpha and TNF-beta by human mononuclear cells: a possible link to insulin-dependent diabetes mellitus. Eur J Immunol 1993; 23: 224-231.
24. D'Alfonso S, Colombo G, Della Bella S, Scroza R, Momigliano-Richiardi P. Association between polymorphisms in the TNF region and systemic lupus erythematosus in the Italian Population. Tissue Antigens 1996; 47: 551-555.
25. McGuire W, Hill AV, Allsopp CE, Greenwood BM, Kwiatkowski D. Variation in the TNF-alpha promoter region associated with susceptibility to cerebral malaria. Nature 1994; 371: 508-810.
26. Mira JP, Cariou A, Grall F et al. Association of TNF2, a TNF-alpha promoter polymorphism, with septic shock susceptibility and mortality: a multicenter study. JAMA 1999; 282: 561-568.
27. Kaijzel EL, van Krugten MV, Brinkman BM et al. Functional analysis of a human tumor necrosis factor alpha (TNF-alpha) promoter polymorphism related to joint damage in rheumatoid arthritis. Molecular Medicine 1998; 4: 724-733.
28. Roberts AK, Monozon-Bordonaba F, Van Deerlin PG et al Association of polymorphism within the promoter of the tumor necrosis factor alpha gene with increased risk of the fetal membranes. Am J Obste & Gynecol 1999; 180: 1297-1302.
29. Higuchi T, Seki N, Kamizono S et al. Polymorphism of the 5′-franking region of the human tumor necrosis factor (TNF-alpha) gene in Japanese. Tissue Antigens 1998; 51: 605-612.
30. Orimo H, Sugioka Y, Fukunaga H et al. The diagnosis of osteoporosis. Jpn J Bone Miner Res 1996; 14: 219-233.
31. Tsukamoto K, Ota N, Shirai Y, Emi M. A highly polymorphic CA repeat marker at the human tumor necrosis factor alpha (TNF-alpha) locus. J Hum Genet 1998; 43: 278-279.
32. Elston RC. S.A.G.E. program package release 2.2: SIBPAL version 2.7, USPublic Health Service. National Center for Research Resources, 1996.